Drug shortage
Dextrose Monohydrate 5% Injection · Baxter Healthcare
FDA drug shortage · Current · updated Oct 2, 2026
Key facts
| Generic name | Dextrose Monohydrate 5% Injection |
|---|---|
| Company | Baxter Healthcare |
| Presentation | Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-11) |
| Dosage form | Injection |
| Status | Current |
| Reason for shortage | Demand increase for the drug |
| Therapeutic category | Endocrinology/Metabolism Gastroenterology Other Pediatric |
| Package NDCs | 0338-0017-11 |
| First posted | Feb 14, 2022 |
| Last updated | Oct 2, 2026 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: